Vascular Biogenics Ltd

NASDAQ:VBLT   3:59:54 PM EDT
2.05
-0.05 (-2.38%)
Earnings Announcements

Vascular Biogenics Posts Q2 Revenue Of $188,000

Published: 08/16/2021 11:29 GMT
Vascular Biogenics Ltd (VBLT) - Vbl Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update.
Q2 Revenue $188,000.
Q2 Revenue Estimate $325,000 -- Refinitiv Ibes Data (analyst estimates).
Qtrly Loss per Share $0.12.
Q2 Earnings per Share View $-0.11 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0.15 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0.15 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.